These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 22014032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G.
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [Abstract] [Full Text] [Related]

  • 4. In vitro properties of platelets stored in three different additive solutions.
    Tynngård N, Trinks M, Berlin G.
    Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
    [Abstract] [Full Text] [Related]

  • 5. Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.
    Zeddies S, De Cuyper IM, van der Meer PF, Daal BB, de Korte D, Gutiérrez L, Thijssen-Timmer DC.
    Transfusion; 2014 Sep; 54(9):2292-300. PubMed ID: 24689812
    [Abstract] [Full Text] [Related]

  • 6. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
    van der Meer PF, Bontekoe IJ, Daal BB, de Korte D.
    Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
    [Abstract] [Full Text] [Related]

  • 7. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions.
    Tynngård N, Trinks M, Berlin G.
    Vox Sang; 2012 Jan; 102(1):32-9. PubMed ID: 21534983
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
    AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP.
    Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
    [Abstract] [Full Text] [Related]

  • 9. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
    Picker SM, Steisel A, Gathof BS.
    Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model.
    Chi X, Zhi L, Vostal JG.
    Transfusion; 2014 Jan; 54(1):74-85. PubMed ID: 23656563
    [Abstract] [Full Text] [Related]

  • 14. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM, Steisel A, Gathof BS.
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
    Ambruso DR, Thurman G, Marschner S, Goodrich RP.
    Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
    [Abstract] [Full Text] [Related]

  • 17. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies.
    Picker SM, Schneider V, Oustianskaia L, Gathof BS.
    Transfusion; 2009 Nov; 49(11):2311-8. PubMed ID: 19624608
    [Abstract] [Full Text] [Related]

  • 18. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P, Mayaudon V, Payrat JM, Sjödin A, Gulliksson H.
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.